Original Research

Published on 02 May 2024

Effect of computerized cognitive remediation therapy on mental time travel in patients with schizophrenia— a pilot randomized controlled trial

in Schizophrenia

Junhua Cao
Cao Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1363290

Original Research

Accepted on 01 May 2024

Empathy in schizophrenia: Neural alterations during emotion recognition and affective sharing

in Schizophrenia

Simon Knobloch
Delia Leiding
Lisa Wagels
Christina Regenbogen
Thilo Kellermann
Klaus Mathiak
Frank Schneider
Birgit Derntl
Ute Habel

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1288028

Original Research

Accepted on 01 May 2024

Homocysteine levels in first-episode patients with psychiatric disorders

in Schizophrenia

Ning Fan
Wenxuan Zhao
Yajun Yun
Luyuan Bai
Huimei An
Qi Zhang
Jiangling Yan
Fengmei Fan
Xiaole Han
Fude Yang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1380900

Original Research

Accepted on 01 May 2024

Implementation of guidelines on Family Involvement for persons with Psychotic disorders (IFIP): a pragmatic cluster randomized trial. Impact Effect on relatives’ outcomes and the provision of family interventions received

in Schizophrenia

Irene Norheim
Reidar Pedersen
Maria Lie Selle
Jan Ivar Røssberg
Lars Hestmark
Kristin Sverdvik Heiervang
Torleif Ruud
Vilde Maria Åsholt
Kristiane Myckland Hansson
Paul Møller

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1381007

Review

Published on 30 Apr 2024

Bipolar disorders and schizophrenia: discrete disorders?

in Schizophrenia

Micaela Dines
Mariana Kes
Delfina Ailán
Marcelo Cetkovich-Bakmas
Christoph Born
Heinz Grunze

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1352250

353 views

Original Research

Published on 30 Apr 2024

Daily-life stress reactivity and recovery following virtual-reality-based cognitive behavioral therapy in patients with a psychotic disorder

in Schizophrenia

Elisabeth C. D. van der Stouwe
Sanne H. Booij
Chris N. W. Geraets
Roos M. C. A. Pot-Kolder
Anna Kuranova
Mark van der Gaag
Wim Veling

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1360165

Review

Accepted on 29 Apr 2024

How schizophrenia is seen in social networks: a review of the literature.Social networks use in the context of schizophrenia: a review of the literature

in Schizophrenia

Carolina Suárez-Llevat
Beatriz Jiménez-Gómez
Carlos Ruiz-Nuñez
Invención Fernández-Quijano
Eva María Rodriguez-González
Carlos De La Torre-Domingo
Ivan Herrera-Peco

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1255073

Correction

Accepted on 29 Apr 2024

Corrigendum: Psychosocial stress moderates the relationship between cerebrospinal fluid lactate dehydrogenase and the duration of untreated psychosis in first-episode psychosis

in Schizophrenia

Eloi Giné-Servén
Ester Boix-Quintana
Eva Daví-Loscos
Sandra Cepedello
Lara Moreno-Sancho
Marta Niubó
Rebeca Hernández-Antón
Manuel J Cuesta
Javier Labad

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1398682

Original Research

Accepted on 29 Apr 2024

Adverse Childhood Experiences among People with Schizophrenia at Comprehensive Specialized Hospitals in Bahir Dar, Ethiopia: A Comparative study

in Schizophrenia

Birhanu Assefa
Tilahun Belete
Rekik Damtew
Tilahun Bete
Solomon Moges

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1387833

Original Research

Accepted on 29 Apr 2024

Emotional Tone in Clinical High Risk for Psychosis: Novel Insights from a Natural Language Analysis Approach

in Schizophrenia

Gabrielle M. Olson
Katherine S. F. Damme
Henry R. Cowan
Luz Maria Alliende
Vijay A. Mittal

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1389597

Original Research

Published on 29 Apr 2024

Gender differences in cognitive improvements after two months of atypical antipsychotic treatment in first episode schizophrenia

in Schizophrenia

Wanyi Li
Xiang Cao
Qian Liang
Yan Li
Chao Zhou
Jinglun Du
Shiping Xie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1369532

108 views

Original Research

Accepted on 26 Apr 2024

Factorial structure of the Comprehensive Assessment of At-Risk Mental States in help-seeking individuals: mapping the structure and the prediction of subsequent transition to psychosis

in Schizophrenia

Cristiana Montemagni
Anna Carluccio
Claudio Brasso
Paola Rocca

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1381133

Systematic Review

Accepted on 26 Apr 2024

Transdiagnostic Markers Across the Psychosis Continuum: A Systematic Review and Meta-Analysis of Resting State fMRI Studies

in Schizophrenia

Giuseppe Pierpaolo Merola
Livio Tarchi
Luigi F Saccaro
Farnaz Delavari
Camille Piguet
Dimitri Van De Ville
Giovanni Castellini
Valdo Ricca

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1378439

Clinical Trial

Published on 26 Apr 2024

Effect of applying nursing-based cognitive defusion techniques on mindful awareness, cognitive fusion, and believability of delusions among clients with schizophrenia: a randomized control trial

in Schizophrenia

Ayman Mohamed El-Ashry
Eman Sameh Abd Elhay
Samah Mohamed Taha
Mahmoud Abdelwahab Khedr
Feby Saad Attalla Mansour
Amany Anwar Saeed Alabdullah
Sally Mohammed Farghaly Abdelaliem
Mona Metwally El-Sayed

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1369160

327 views

Original Research

Published on 24 Apr 2024

Increased brain gyrification and cortical thinning in winter-born patients with schizophrenia spectrum

in Schizophrenia

Misako Torigoe
Tsutomu Takahashi
Yoichiro Takayanagi
Daiki Sasabayahi
Haruko Kobayashi
Kazumi Sakamoto
Yusuke Yuasa
Noa Tsujii
Kyo Noguchi
Michio Suzuki

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1368681

186 views

Mini Review

Published on 23 Apr 2024

Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen

in Schizophrenia

Kennadi Johnson
Abby J. Weldon
Melissa A. Burmeister

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1386263

455 views

Navigation group

Articles

Effect of computerized cognitive remediation therapy on mental time travel in patients with schizophrenia— a pilot randomized controlled trial

Empathy in schizophrenia: Neural alterations during emotion recognition and affective sharing

Homocysteine levels in first-episode patients with psychiatric disorders

Implementation of guidelines on Family Involvement for persons with Psychotic disorders (IFIP): a pragmatic cluster randomized trial. Impact Effect on relatives’ outcomes and the provision of family interventions received

Bipolar disorders and schizophrenia: discrete disorders?

Daily-life stress reactivity and recovery following virtual-reality-based cognitive behavioral therapy in patients with a psychotic disorder

How schizophrenia is seen in social networks: a review of the literature.Social networks use in the context of schizophrenia: a review of the literature

Corrigendum: Psychosocial stress moderates the relationship between cerebrospinal fluid lactate dehydrogenase and the duration of untreated psychosis in first-episode psychosis

Adverse Childhood Experiences among People with Schizophrenia at Comprehensive Specialized Hospitals in Bahir Dar, Ethiopia: A Comparative study

Emotional Tone in Clinical High Risk for Psychosis: Novel Insights from a Natural Language Analysis Approach

Gender differences in cognitive improvements after two months of atypical antipsychotic treatment in first episode schizophrenia

Factorial structure of the Comprehensive Assessment of At-Risk Mental States in help-seeking individuals: mapping the structure and the prediction of subsequent transition to psychosis

Transdiagnostic Markers Across the Psychosis Continuum: A Systematic Review and Meta-Analysis of Resting State fMRI Studies

Effect of applying nursing-based cognitive defusion techniques on mindful awareness, cognitive fusion, and believability of delusions among clients with schizophrenia: a randomized control trial

Increased brain gyrification and cortical thinning in winter-born patients with schizophrenia spectrum

Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen